Literature DB >> 25814066

Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency.

Michael J Ciancanelli1, Sarah X L Huang2, Priya Luthra3, Hannah Garner4, Yuval Itan1, Stefano Volpi5, Fabien G Lafaille1, Céline Trouillet4, Mirco Schmolke3, Randy A Albrecht6, Elisabeth Israelsson7, Hye Kyung Lim1, Melina Casadio1, Tamar Hermesh1, Lazaro Lorenzo8, Lawrence W Leung3, Vincent Pedergnana8, Bertrand Boisson1, Satoshi Okada9, Capucine Picard10, Benedicte Ringuier11, Françoise Troussier12, Damien Chaussabel13, Laurent Abel14, Isabelle Pellier15, Luigi D Notarangelo16, Adolfo García-Sastre17, Christopher F Basler3, Frédéric Geissmann4, Shen-Ying Zhang14, Hans-Willem Snoeck2, Jean-Laurent Casanova18.   

Abstract

Severe influenza disease strikes otherwise healthy children and remains unexplained. We report compound heterozygous null mutations in IRF7, which encodes the transcription factor interferon regulatory factor 7, in an otherwise healthy child who suffered life-threatening influenza during primary infection. In response to influenza virus, the patient's leukocytes and plasmacytoid dendritic cells produced very little type I and III interferons (IFNs). Moreover, the patient's dermal fibroblasts and induced pluripotent stem cell (iPSC)-derived pulmonary epithelial cells produced reduced amounts of type I IFN and displayed increased influenza virus replication. These findings suggest that IRF7-dependent amplification of type I and III IFNs is required for protection against primary infection by influenza virus in humans. They also show that severe influenza may result from single-gene inborn errors of immunity.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25814066      PMCID: PMC4431581          DOI: 10.1126/science.aaa1578

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  32 in total

1.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

Authors:  Hiroki Kato; Osamu Takeuchi; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Kosuke Matsui; Satoshi Uematsu; Andreas Jung; Taro Kawai; Ken J Ishii; Osamu Yamaguchi; Kinya Otsu; Tohru Tsujimura; Chang-Sung Koh; Caetano Reis e Sousa; Yoshiharu Matsuura; Takashi Fujita; Shizuo Akira
Journal:  Nature       Date:  2006-04-09       Impact factor: 49.962

2.  The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts.

Authors:  Xiuyan Wang; Ella R Hinson; Peter Cresswell
Journal:  Cell Host Microbe       Date:  2007-08-16       Impact factor: 21.023

Review 3.  The genetic theory of infectious diseases: a brief history and selected illustrations.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-05-29       Impact factor: 8.929

4.  RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

Authors:  Jan Rehwinkel; Choon Ping Tan; Delphine Goubau; Oliver Schulz; Andreas Pichlmair; Katja Bier; Nicole Robb; Frank Vreede; Wendy Barclay; Ervin Fodor; Caetano Reis e Sousa
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

5.  Influenza virus partially counteracts restriction imposed by tetherin/BST-2.

Authors:  Bastien Mangeat; Lorris Cavagliotti; Martin Lehmann; Gustavo Gers-Huber; Inderdeep Kaur; Yves Thomas; Laurent Kaiser; Vincent Piguet
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

6.  Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7.

Authors:  Alexandre Caillaud; Ara G Hovanessian; David E Levy; Isabelle J Marié
Journal:  J Biol Chem       Date:  2005-03-02       Impact factor: 5.157

7.  Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7.

Authors:  I Marié; J E Durbin; D E Levy
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7.

Authors:  M Sato; N Hata; M Asagiri; T Nakaya; T Taniguchi; N Tanaka
Journal:  FEBS Lett       Date:  1998-12-11       Impact factor: 4.124

9.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

10.  Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies.

Authors:  Jean-Laurent Casanova; Mary Ellen Conley; Stephen J Seligman; Laurent Abel; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2014-10-13       Impact factor: 14.307

View more
  202 in total

1.  The microbial metabolite desaminotyrosine protects from influenza through type I interferon.

Authors:  Ashley L Steed; George P Christophi; Gerard E Kaiko; Lulu Sun; Victoria M Goodwin; Umang Jain; Ekaterina Esaulova; Maxim N Artyomov; David J Morales; Michael J Holtzman; Adrianus C M Boon; Deborah J Lenschow; Thaddeus S Stappenbeck
Journal:  Science       Date:  2017-08-04       Impact factor: 47.728

2.  Genomics is rapidly advancing precision medicine for immunological disorders.

Authors:  Yu Zhang; Helen C Su; Michael J Lenardo
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

Review 3.  Translating nucleic acid-sensing pathways into therapies.

Authors:  Tobias Junt; Winfried Barchet
Journal:  Nat Rev Immunol       Date:  2015-08-21       Impact factor: 53.106

Review 4.  Genomics of Immune Diseases and New Therapies.

Authors:  Michael Lenardo; Bernice Lo; Carrie L Lucas
Journal:  Annu Rev Immunol       Date:  2015-12-23       Impact factor: 28.527

5.  Profile of Jean-Laurent Casanova.

Authors:  Prashant Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

Review 6.  Inflammation and Pneumonia: Why Are Some More Susceptible than Others?

Authors:  Joseph P Mizgerd
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

7.  Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.

Authors:  Samira Asgari; Luregn J Schlapbach; Stéphanie Anchisi; Christian Hammer; Istvan Bartha; Thomas Junier; Geneviève Mottet-Osman; Klara M Posfay-Barbe; David Longchamp; Martin Stocker; Samuel Cordey; Laurent Kaiser; Thomas Riedel; Tony Kenna; Deborah Long; Andreas Schibler; Amalio Telenti; Caroline Tapparel; Paul J McLaren; Dominique Garcin; Jacques Fellay
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

8.  SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.

Authors:  E Kaitlynn Allen; Adrienne G Randolph; Tushar Bhangale; Pranay Dogra; Maikke Ohlson; Christine M Oshansky; Anthony E Zamora; John P Shannon; David Finkelstein; Amy Dressen; John DeVincenzo; Miguela Caniza; Ben Youngblood; Carrie M Rosenberger; Paul G Thomas
Journal:  Nat Med       Date:  2017-07-17       Impact factor: 53.440

Review 9.  Antiviral innate immunity through the lens of systems biology.

Authors:  Shashank Tripathi; Adolfo Garcia-Sastre
Journal:  Virus Res       Date:  2015-12-03       Impact factor: 3.303

10.  Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes.

Authors:  Mahesh Chemudupati; Adam D Kenney; Anna C Smith; Robert J Fillinger; Lizhi Zhang; Ashley Zani; Shan-Lu Liu; Matthew Z Anderson; Amit Sharma; Jacob S Yount
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.